Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Preferred Shares Issued (2022 - 2023)

Cullinan Therapeutics (CGEM) has 2 years of Preferred Shares Issued data on record, last reported at $1.8 million in Q1 2023.

  • For Q1 2023, Preferred Shares Issued rose 128.12% year-over-year to $1.8 million; the TTM value through Dec 2023 reached $1.8 million, down 23.16%, while the annual FY2023 figure was $1.8 million, 23.16% down from the prior year.
  • Preferred Shares Issued reached $1.8 million in Q1 2023 per CGEM's latest filing, up from $175000.0 in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $1.8 million in Q1 2023 and bottomed at $175000.0 in Q4 2022.